ArticleAmerican journal of translational research2026

Remimazolam impairs bone marrow mesenchymal stem cell function and attenuates the tumor-promoting ability.

Yan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.